Reproducibility of 18F Uptake by Solid Tumors Using PET Imaging Following Intravenous Administration of (18F) Injection
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Solid Tumors|High Grade Gliomas|Lung Cancer|Head and Neck Cancer|Sarcoma|Renal Cell Carcinoma|Breast Cancer
Interventions: DRUG: Fluciclatide Injection
Sponsor: GE Healthcare
Collaborators: BIAFFIN GmbH & Co. KG (Biomolecular Interaction Analyses)|Quintiles, Inc.|i3 Statprobe